Arnold Ventures Submitted Comments to Administrator Oz the Global Benchmark for Efficient Drug Pricing (GLOBE) Model

In comments to the Centers for Medicare and Medicaid Services (CMS) Arnold Ventures offers support for the GLOBE Model to test a framework for lowering the prices of high-cost brand-name drugs purchased by Medicare, which could create savings for taxpayers and Medicare beneficiaries. AV provides comments on select sections, and requests clarification about whether participation in other CMMI models or Most Favored Nation deals would allow manufacturers to opt out of the GLOBE Model.